
FDA Approves Viridian’s Lumvoa for Thyroid Eye Disease
As reported on PharmaBiz, the U.S. Food and Drug Administration (FDA) has approved Lumvoa (veligrotug‑vvze), a new therapy developed by Viridian Therapeutics, for the treatment

As reported on PharmaBiz, the U.S. Food and Drug Administration (FDA) has approved Lumvoa (veligrotug‑vvze), a new therapy developed by Viridian Therapeutics, for the treatment

As reported by PharmaBiz, Eli Lilly and Company has announced positive findings from its Phase 3 BRUIN CLL-322 trial evaluating pirtobrutinib (Jaypirca), a next-generation non-covalent

As reported on PharmaTimes, the United Arab Emirates has taken a significant step toward preventive neurology with the initiation of its first clinical trial guided

As reported by Yahoo Finance, the U.S. Food and Drug Administration (FDA) has accepted for review two applications from Sandoz for generic versions of tirzepatide,

As reported on FiercePharma, the U.S. Food and Drug Administration (FDA) has selected seven pharmaceutical and biotechnology companies to participate in its newly established PreCheck

As reported on Healio, the U.S. Food and Drug Administration has broadened the indication for roflumilast cream 0.3% (Zoryve, Arcutis), allowing its use in children

Editor’s Note: Patient Worthy is honored to share this story from our friends at Elephants & Tea, originally written by Amy Hoffmann — a survivor

One of the hardest things about living with dystonia is trying to explain what it feels like on the inside. People often see (not always for some) the muscle

Editor’s Note: Patient Worthy is honored to share this article, provided by our friends at the TREND Community. To see the article in its original

Editor’s Note: This article was originally published by Patient Worthy on 6/7/24, and is being republished due to our ongoing efforts to raise awareness of

Editor’s Note: This article is brought to you by our friends at the Acromegaly Community, and shared with our audience at their request. To learn

Editor’s Note: This article by Tom Seaman was originally shared by Patient Worthy on 12/15/22. I believe very strongly in the power of thoughts and

A recent BBC report highlighted a forthcoming clinical trial examining puberty-suppressing medications in young people is being positioned by its proponents as a necessary step

As reported on MedCity News, Eli Lilly has reported encouraging early-stage clinical data for AJ1-11095, an investigational therapy for myelofibrosis acquired through its recent purchase

My name is Les Howard, and I am living with hypertrophic obstructive cardiomyopathy (HCM). Looking back, I believe I may have lived with HCM for most

As reported on PharmaBiz, Sumitomo Pharma America (SMPA) presented new clinical and translational data spanning myelofibrosis (MF) and acute leukemia programs at the 2026 European

In the United States, colorectal cancer represents the third most frequently diagnosed malignancy and the second leading cause of cancer-related death. A colonoscopy continues to

Grifols, as announced in a recent press release, has officially launched FESILTY™ (fibrinogen, human-chmt) in the United States. The therapy is approved to treat sudden,
💙 Diagnosis Is More Than a Test—It's a Step Toward Understanding
For people living with Peripheral Nerve Injury (PNI), getting answers can be an important part of the journey. Understanding the cause of symptoms can help patients feel more informed, empowered, and prepared to discuss their care with their healthcare team.
While the path to a diagnosis may look different for everyone, having the right information can open the door to better symptom management and support. Just as importantly, connecting with others who share similar experiences can provide encouragement and remind us that we're not alone. Follow Patient Worthy across our social channels as we explore the symptoms, challenges, and real-life experiences of those affected by PNI. And if you’re living with PNI or caring for someone who is, we’d love to hear your story—click the link below, to share your journey.
ow.ly/AWx550ZjPRF
#PNI #PeripheralNerveInjury #DiagnosisJourney #PatientAdvocacy #PatientWorthy #NerveHealth #HealthAwareness #ShareYourStory
... See MoreSee Less


+3
Grief doesn't only come after loss—it can also come with the life you imagined but didn't get to live.
Many people with chronic illnesses or rare diseases grieve the plans they had, the energy they once had, the independence they expected, or the future they pictured for themselves. Those feelings can exist alongside hope, resilience, and joy.
Making space for that grief doesn't mean you've given up. It means you're acknowledging a very real part of the journey.
#chronicillness #invisibleillness #raredisease #youarenotalone #quote #PatientWorthy
... See MoreSee Less

Living with Peripheral Nerve Injury (PNI) can bring unique challenges, but knowledge, awareness, and support can make a difference. By learning more about PNI and sharing experiences, patients, caregivers, and advocates can help build a stronger, more informed community.
💙 Stay informed. Stay connected. Stay inspired.
Follow Patient Worthy for more PNI facts, resources, and patient stories.
if you’re living with PNI or caring for someone who is, we’d love to hear your story—click the link below, to share your journey and help inspire others in the community.
ow.ly/unzv50ZjOFK
#PNI #PeripheralNerveInjury #PatientWorthy #ShareYourStory #StrongerTogether #PatientAdvocacy
... See MoreSee Less


+2
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
What best describes you when it comes to rare disease? (check all that apply)
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.